Tudor Investment Corp’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-21,760
| Closed | -$1.98M | – | 2098 |
|
|
2023
Q1 | $1.98M | Buy |
+21,760
| New | +$1.98M | 0.03% | 648 |
|
|
2022
Q4 | – | Sell |
-11,833
| Closed | -$297K | – | 2095 |
|
|
2022
Q3 | $297K | Buy |
11,833
+302
| +3% | +$7.58K | 0.01% | 1296 |
|
|
2022
Q2 | $350K | Sell |
11,531
-1,644
| -12% | -$49.9K | 0.01% | 1192 |
|
|
2022
Q1 | $432K | Buy |
13,175
+4,293
| +48% | +$141K | 0.01% | 1154 |
|
|
2021
Q4 | $234K | Sell |
8,882
-11,102
| -56% | -$292K | ﹤0.01% | 1418 |
|
|
2021
Q3 | $2.01M | Buy |
19,984
+4,360
| +28% | +$439K | 0.03% | 571 |
|
|
2021
Q2 | $2.21M | Sell |
15,624
-6,461
| -29% | -$914K | 0.04% | 491 |
|
|
2021
Q1 | $2.2M | Buy |
22,085
+8,859
| +67% | +$883K | 0.04% | 473 |
|
|
2020
Q4 | $1.64M | Buy |
+13,226
| New | +$1.64M | 0.05% | 489 |
|
|
2020
Q3 | – | Sell |
-7,666
| Closed | -$1.2M | – | 1591 |
|
|
2020
Q2 | $1.2M | Buy |
7,666
+1,740
| +29% | +$271K | 0.06% | 415 |
|
|
2020
Q1 | $855K | Sell |
5,926
-2,340
| -28% | -$338K | 0.08% | 293 |
|
|
2019
Q4 | $1.69M | Buy |
+8,266
| New | +$1.69M | 0.08% | 337 |
|